Advanced search
Publication Cover
Virulence Volume 13, 2022 - Issue 1
Submit an article Journal homepage
4,688
Views
6
CrossRef citations to date
0
Altmetric
Research Paper

ABO blood group is involved in the quality of the specific immune response anti-SARS-CoV-2

Sergio Gil-Mansoa Laboratory of Immune- Gregorio Marañón Health Research Institute (IiSGM), Gregorio Marañón University General Hospital, Madrid, SpainORCID Iconhttps://orcid.org/0000-0003-2480-3628View further author information
ORCID Icon,
Iria Miguens Blancob Department of Emergency, Gregorio Marañón University General Hospital, Madrid, SpainView further author information
,
Bruce Motykac Department of Pediatrics, Alberta Transplant Institute and Canadian Donation and Transplantation Research Program; University of Alberta, Edmonton, Alberta, CanadaORCID Iconhttps://orcid.org/0000-0002-8448-2777View further author information
ORCID Icon,
Anne Halpinc Department of Pediatrics, Alberta Transplant Institute and Canadian Donation and Transplantation Research Program; University of Alberta, Edmonton, Alberta, Canada;d Laboratory Medicine & Pathology, University of Alberta, Edmonton, Alberta, CanadaORCID Iconhttps://orcid.org/0000-0001-7475-9245View further author information
ORCID Icon,
Rocío López-Estebana Laboratory of Immune- Gregorio Marañón Health Research Institute (IiSGM), Gregorio Marañón University General Hospital, Madrid, SpainView further author information
,
Verónica Astrid Pérez-Fernándeza Laboratory of Immune- Gregorio Marañón Health Research Institute (IiSGM), Gregorio Marañón University General Hospital, Madrid, SpainView further author information
,
Diego Carbonella Laboratory of Immune- Gregorio Marañón Health Research Institute (IiSGM), Gregorio Marañón University General Hospital, Madrid, Spain;e Department of Hematology, Gregorio Marañón University General Hospital, Madrid, SpainORCID Iconhttps://orcid.org/0000-0003-2960-0301View further author information
ORCID Icon,
Luis Andrés López-Fernándezf Service of Pharmacy, Gregorio Marañón Health Research Institute (IiSGM), Gregorio Marañón University General Hospital, Spanish Clinical Research Network (SCReN), Madrid, SpainView further author information
,
Lori Westc Department of Pediatrics, Alberta Transplant Institute and Canadian Donation and Transplantation Research Program; University of Alberta, Edmonton, Alberta, Canada;g Medical Microbiology & Immunology, Surgery, and Laboratory Medicine & Pathology; University of Alberta, Edmonton, Alberta, CanadaORCID Iconhttps://orcid.org/0000-0002-1990-3651View further author information
ORCID Icon,
Rafael Correa-Rochaa Laboratory of Immune- Gregorio Marañón Health Research Institute (IiSGM), Gregorio Marañón University General Hospital, Madrid, SpainCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-3456-9986View further author information
ORCID Icon &
Marjorie Piona Laboratory of Immune- Gregorio Marañón Health Research Institute (IiSGM), Gregorio Marañón University General Hospital, Madrid, SpainCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-1828-4745View further author information
ORCID Icon show all
Pages 30-45 | Received 16 Aug 2021, Accepted 09 Dec 2021, Published online: 30 Dec 2021

References

  • Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel Coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069 doi:10.1001/jama.2020.1585. PubMed PMID: 32031570; PubMed Central PMCID: PMCPMC7042881.
  • Pascarella G, Strumia A, Piliego C, et al. COVID-19 diagnosis and management: a comprehensive review. J Intern Med. 2020;288(2):192–206 doi:10.1111/joim.13091. Epub 2020/05/13.
  • Greenhalgh T, Knight M, A’Court C, et al. Management of post-acute covid-19 in primary care. BMJ. 2020;370:m3026 doi:10.1136/bmj.m3026 doi:. Epub 2020/08/11. PubMed PMID: 32784198.
  • Carfì A, Bernabei R, Landi F, et al. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603–605 doi:10.1001/jama.2020.12603. PubMed PMID: 32644129; PubMed Central PMCID: PMCPMC7349096.
  • Rubin R. As their numbers grow, COVID-19 ”Long Haulers” stump experts. JAMA. 2020; Epub 2020/09/23. PubMed PMID: 32965460. doi: 10.1001/jama.2020.17709.
  • Huang Y, Pinto MD, Borelli JL, et al. COVID symptoms, symptom clusters, and predictors for becoming a long-hauler: looking for clarity in the haze of the pandemic. medRxiv. 2021; Epub 2021/03/05. PubMed PMID: 33688670; PubMed Central PMCID: PMCPMC7941647. doi: 10.1101/2021.03.03.21252086.
  • Beaudoin-Bussières G, Laumaea A, Anand SP, et al. Decline of humoral responses against SARS-CoV-2 spike in convalescent individuals. mBio. 2020;11(5): Epub 2020/10/16. PubMed PMID: 33067385; PubMed Central PMCID: PMCPMC7569150. doi: 10.1128/mBio.02590-20.
  • Long QX, Liu BZ, Deng HJ, et al. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat Med. 2020;26(6):845–848 doi:10.1038/s41591-020-0897-1. Epub 2020/04/29. PubMed PMID: 32350462.
  • Ogega CO, Skinner NE, Blair PW, et al. Durable SARS-CoV-2 B cell immunity after mild or severe disease. medRxiv. 2020; Epub 2020/10/30. PubMed PMID: 33140070; PubMed Central PMCID: PMCPMC7605583. doi: 10.1101/2020.10.28.20220996.
  • SeyedAlinaghi S, Oliaei S, Kianzad S, et al. Reinfection risk of novel coronavirus (COVID-19): a systematic ‎review of current evidence. World J Virol. 2020;9(5):79–90 doi:10.5501/wjv.v9.i5.79. PubMed PMID: 33363000; PubMed Central PMCID: PMCPMC7747024.
  • Gousseff M, Penot P, Gallay L, et al. Clinical recurrences of COVID-19 symptoms after recovery: viral relapse, reinfection or inflammatory rebound? J Infect. 2020;81(5):816–846 doi:10.1016/j.jinf.2020.06.073. Epub 2020/06/30. PubMed PMID: 32619697; PubMed Central PMCID: PMCPMC7326402.
  • To KK, Hung IF, Ip JD, et al. COVID-19 re-infection by a phylogenetically distinct SARS-coronavirus-2 strain confirmed by whole genome sequencing. Clin Infect Dis. 2020; Epub 2020/08/25. PubMed PMID: 32840608; PubMed Central PMCID: PMCPMC7499500. doi: 10.1093/cid/ciaa1275.
  • Kim DS, Rowland-Jones S, Gea-Mallorquí E. Will SARS-CoV-2 infection elicit long-lasting protective or sterilising immunity? implications for vaccine strategies (2020). Front Immunol. 2020;11:571481 doi:10.3389/fimmu.2020.571481. Epub 2020/12/09.
  • Bilich T, Nelde A, Heitmann JS, et al. Differential kinetics of T cell and antibody responses delineate dominant T cell epitopes in long-term immunity after COVID-19. Cell. 2021; DOI:10.2139/ssrn.3713528.
  • Peluso MJ, Deitchman AN, Torres L, et al. Long-Term SARS-CoV-2-Specific immune and inflammatory responses across a clinically diverse cohort of individuals recovering from COVID-19. medRxiv. 2021; Epub 2021/03/01. PubMed PMID: 33688685; PubMed Central PMCID: PMCPMC7941662. doi: 10.1101/2021.02.26.21252308.
  • Ng OW, Chia A, Tan AT, et al. Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection. Vaccine. 2016;34(17):2008–2014 doi:10.1016/j.vaccine.2016.02.063. Epub 2016/03/05. PubMed PMID: 26954467; PubMed Central PMCID: PMCPMC7115611.
  • Prévost J, Gasser R, Beaudoin-Bussières G, et al. Cross-sectional evaluation of humoral responses against SARS-CoV-2 Spike. Cell Rep Med. 2020;1(7):100126 doi:10.1016/j.xcrm.2020.100126. Epub 2020/09/30. PubMed PMID: 33015650; PubMed Central PMCID: PMCPMC7524645.
  • Grifoni A, Weiskopf D, Ramirez SI, et al. Targets of T cell responses to SARS-CoV-2 Coronavirus in humans with COVID-19 disease and unexposed individuals. Cell. 2020;181(7):1489–501.e15 doi:10.1016/j.cell.2020.05.015. Epub 2020/05/20. PubMed PMID: 32473127; PubMed Central PMCID: PMCPMC7237901.
  • Le Bert N, Tan AT, Kunasegaran K, et al. SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls. Nature. 2020;584(7821):457–462 doi:10.1038/s41586-020-2550-z. Epub 2020/07/15. PubMed PMID: 32668444.
  • Sekine T, Perez-Potti A, Rivera-Ballesteros O, et al. Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19. Cell. 2020;183(1):158–68.e14 doi:10.1016/j.cell.2020.08.017. Epub 2020/08/14. PubMed PMID: 32979941; PubMed Central PMCID: PMCPMC7427556.
  • Marshall JC, Murthy S, Diaz J, et al.infection WWGotCCaMoC-. A minimal common outcome measure set for COVID-19 clinical research.Lancet Infect Dis.2020;20(8):e192–e7 doi:10.1016/S1473-3099(20)30483-7. Epub 2020/06/12. PubMed PMID: 32539990; PubMed Central PMCID: PMCPMC7292605.
  • Bentall A, Jeyakanthan M, Braitch M, et al. Characterization of ABH-subtype donor-specific antibodies in ABO-A-incompatible kidney transplantation. Am J Transplant. 2021;21(11):3649–3662 doi:10.1111/ajt.16712. Epub 20210608. PubMed PMID: 34101982.
  • Jeyakanthan M, Meloncelli PJ, Zou L, et al. ABH-glycan microarray characterizes ABO subtype antibodies: fine specificity of immune tolerance after ABO-incompatible transplantation. Am J Transplant. 2016;16(5):1548–1558 doi:10.1111/ajt.13625. Epub 2016/01/25. PubMed PMID: 26602221.
  • Stephen A, Shubhagata D, Sherry D, et al. XMAP Cookbook: a collection of methods and protocols for developing multiplex assays with xMAP technolog. Austin TX2018: Corporation L, editor. 2014.
  • Halpin A, Pearcey J, Lowary TL, et al. Modernizing ABO antibody detection: time for new methodologies to support ABO-incompatible transplantation? ASHI Quaterly. 2018;42(4):14–18.
  • Jeyakanthan M, Tao K, Zou L, et al. Chemical basis for qualitative and quantitative differences between ABO blood groups and subgroups: implications for organ transplantation. Am J Transplant. 2015;15(10):2602–2615 doi:10.1111/ajt.13328. Epub 2015/05/26. PubMed PMID: 26014598.
  • Bilich T, Nelde A, Heitmann JS, et al. T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals. Sci Transl Med. 2021;13(590): Epub 2021/03/15. PubMed PMID: 33723016. doi: 10.1126/scitranslmed.abf7517.
  • Dan JM, Mateus J, Kato Y, et al. Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection. Science. 2021;371(6529): Epub 2021/01/06. PubMed PMID: 33408181. doi: 10.1126/science.abf4063.
  • Breton G, Mendoza P, Hagglof T, et al. Persistent cellular immunity to SARS-CoV-2 infection. bioRxiv. 2020; Epub 2020/12/09. PubMed PMID: 33330867; PubMed Central PMCID: PMCPMC7743071. doi: 10.1101/2020.12.08.416636.
  • Gutiérrez-Bautista JF, Rodriguez-Nicolas A, Rosales-Castillo A, et al. Negative clinical evolution in COVID-19 patients is frequently accompanied with an increased proportion of undifferentiated th cells and a strong underrepresentation of the Th1 subset. Front Immunol. 2020;11:596553 doi:10.3389/fimmu.2020.596553. Epub 2020/11/26. PubMed PMID: 33324414; PubMed Central PMCID: PMCPMC7726249.
  • Sercan O, Stoycheva D, Hämmerling GJ, et al.IFN-gamma receptor signaling regulates memory CD8+ T cell differentiation.J Immunol.2010;184(6):2855–2862 doi:10.4049/jimmunol.0902708. Epub 2010/02/17. PubMed PMID: 20164422.
  • Zhou C, Huang Z, Tan W, et al. Predictive factors of severe coronavirus disease 2019 in previously healthy young adults: a single-center, retrospective study. Respir Res. 2020;21(1):157 doi:10.1186/s12931-020-01412-1. Epub 2020/06/22. PubMed PMID: 32571410; PubMed Central PMCID: PMCPMC7306646.
  • Mayoral EP, Hernández-Huerta MT, Pérez-Campos Mayoral L, et al. Factors related to asymptomatic or severe COVID-19 infection. Med Hypotheses. 2020;144:110296 doi:10.1016/j.mehy.2020.110296. Epub 2020/09/24. PubMed PMID: 33254487; PubMed Central PMCID: PMCPMC7513914.
  • Anastassopoulou C, Gkizarioti Z, Patrinos GP, et al.Human genetic factors associated with susceptibility to SARS-CoV-2 infection and COVID-19 disease severity.Hum Genomics.2020;14(1):40 doi:10.1186/s40246-020-00290-4. Epub 2020/10/22. PubMed PMID: 33092637; PubMed Central PMCID: PMCPMC7578581.
  • Padhi S, Suvankar S, Dash D, et al. ABO blood group system is associated with COVID-19 mortality: an epidemiological investigation in the Indian population. Transfus Clin Biol. 2020;27(4):253–258 doi:10.1016/j.tracli.2020.08.009. PubMed PMID: 32987167; PubMed Central PMCID: PMCPMC7518849.
  • Zhao J, Yang Y, Huang H, et al. Relationship between the ABO blood group and the COVID-19 susceptibility. Clin Infect Dis. 2020; Epub 2020/08/04. PubMed PMID: 32750119; PubMed Central PMCID: PMCPMC7454371. doi:10.1093/cid/ciaa1150.
  • Wu Y, Feng Z, Li P, et al. Relationship between ABO blood group distribution and clinical characteristics in patients with COVID-19. Clin Chim Acta. 2020;509:220–223 doi:10.1016/j.cca.2020.06.026. Epub 2020/06/17. PubMed PMID: 32562665.
  • Pendu JL, Breiman A, Rocher J, et al.ABO blood types and COVID-19: spurious, anecdotal, or truly important relationships? A reasoned review of available data.Viruses.2021;13(2):160 doi:10.3390/v13020160. Epub 2021/01/22. PubMed PMID: 33499228; PubMed Central PMCID: PMCPMC7911989.
  • Demaret J, Lefèvre G, Vuotto F, et al. Severe SARS-CoV-2 patients develop a higher specific T-cell response. Clin Transl Immunology. 2020;9(12):e1217 doi:10.1002/cti2.1217. Epub 2020/12/23. PubMed PMID: 33376594; PubMed Central PMCID: PMCPMC7757425.
  • Overgaard NH, Jung JW, Steptoe RJ, et al.CD4+/CD8+ double-positive T cells: more than just a developmental stage?J Leukoc Biol.2015;97(1):31–38 doi:10.1189/jlb.1RU0814-382. Epub 2014/10/30. PubMed PMID: 25360000.
  • Galili U. Host synthesized carbohydrate antigens on viral glycoproteins as ”Achilles’ Heel” of viruses contributing to anti-viral immune protection.Int J Mol Sci. 2020; 21(18): 6702 doi:10.3390/ijms21186702. Epub 2020/09/13. PubMed PMID: 32933166; PubMed Central PMCID: PMCPMC7555091.
  • Deleers M, Breiman A, Daubie V, et al. Covid-19 and blood groups: ABO antibody levels may also matter. Int J Infect Dis. 2021;104:242–249 doi:10.1016/j.ijid.2020.12.025. Epub 2020/12/14. PubMed PMID: 33326874; PubMed Central PMCID: PMCPMC7832075.
  • Guillon P, Clément M, Sébille V, et al. Inhibition of the interaction between the SARS-CoV spike protein and its cellular receptor by anti-histo-blood group antibodies. Glycobiology. 2008;18(12):1085–1093 doi:10.1093/glycob/cwn093. Epub 2008/09/25. PubMed PMID: 18818423; PubMed Central PMCID: PMCPMC7108609.
  • Cohen BH, Bias WB, Chase GA, et al. Is ABH nonsecretor status a risk factor for obstructive lung disease? Am J Epidemiol. 1980;111(3):285–291 doi:10.1093/oxfordjournals.aje.a112898. PubMed PMID: 7361751.
  • Bals R, Woeckel W, Welsch U. Use of antibodies directed against blood group substances and lectins together with glycosidase digestion to study the composition and cellular distribution of glycoproteins in the large human airways. J Anat. 1997;190(1):73–84 doi:10.1046/j.1469-7580.1997.19010073.x. PubMed PMID: 9034883; PubMed Central PMCID: PMCPMC1467585.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.